QUANTUM BIOPHARMA LTD (QNTM) Stock Overview
USA - NASDAQ:QNTM - CA74764Y2050 - Common Stock
QNTM Key Statistics, Chart & Performance
The current stock price of QNTM is 17.13 USD. In the past month the price increased by 4.77%. In the past year, price increased by 344.94%.
QNTM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 45.93 | 702.13B | ||
| JNJ | JOHNSON & JOHNSON | 17.67 | 425.53B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 14.95 | 261.01B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.9 | 238.11B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 16.97 | 233.65B | ||
| MRK | MERCK & CO. INC. | 10.35 | 199.00B | ||
| PFE | PFIZER INC | 7.11 | 136.96B | ||
| SNY | SANOFI-ADR | 10.4 | 113.17B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.56 | 89.89B | ||
| GSK | GSK PLC-SPON ADR | 8.91 | 80.95B | ||
| ZTS | ZOETIS INC | 22.78 | 62.79B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 51.59 | 47.25B |
Related stock screener links
About QNTM
Company Profile
Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. The firm is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc., it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. The firm has also licensed unbuzzd, a formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving individuals from the effects of alcohol consumption. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.
Company Info
QUANTUM BIOPHARMA LTD
55 University Ave. , Suite 1003
TORONTO ONTARIO CA
Employees: 10
Phone: 14168548884
QUANTUM BIOPHARMA LTD / QNTM FAQ
What is the stock price of QUANTUM BIOPHARMA LTD today?
The current stock price of QNTM is 17.13 USD. The price decreased by -6.7% in the last trading session.
What is the ticker symbol for QUANTUM BIOPHARMA LTD stock?
The exchange symbol of QUANTUM BIOPHARMA LTD is QNTM and it is listed on the Nasdaq exchange.
On which exchange is QNTM stock listed?
QNTM stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for QUANTUM BIOPHARMA LTD stock?
7 analysts have analysed QNTM and the average price target is 33.42 USD. This implies a price increase of 95.12% is expected in the next year compared to the current price of 17.13. Check the QUANTUM BIOPHARMA LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is QUANTUM BIOPHARMA LTD worth?
QUANTUM BIOPHARMA LTD (QNTM) has a market capitalization of 65.44M USD. This makes QNTM a Micro Cap stock.
How many employees does QUANTUM BIOPHARMA LTD have?
QUANTUM BIOPHARMA LTD (QNTM) currently has 10 employees.
What are the support and resistance levels for QUANTUM BIOPHARMA LTD (QNTM) stock?
QUANTUM BIOPHARMA LTD (QNTM) has a support level at 15.11 and a resistance level at 18.58. Check the full technical report for a detailed analysis of QNTM support and resistance levels.
Should I buy QUANTUM BIOPHARMA LTD (QNTM) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of QNTM, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of QNTM, evaluating the profitability, health, valuation and growth aspects
- QUANTUM BIOPHARMA LTD (QNTM) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- QUANTUM BIOPHARMA LTD (QNTM) Sales and EPS estimates to see what analysts future expectations are.
- QUANTUM BIOPHARMA LTD (QNTM) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- QUANTUM BIOPHARMA LTD (QNTM) Insider and Institutional Ownership to learn about the owners and their transactions.
- QUANTUM BIOPHARMA LTD (QNTM) Stock Chart to make your own analysis
- QUANTUM BIOPHARMA LTD (QNTM) Latest news and press-releases to stay up to date.
Does QUANTUM BIOPHARMA LTD (QNTM) stock pay dividends?
QNTM does not pay a dividend.
When does QUANTUM BIOPHARMA LTD (QNTM) report earnings?
QUANTUM BIOPHARMA LTD (QNTM) will report earnings on 2025-11-10.
What is the Short Interest ratio of QUANTUM BIOPHARMA LTD (QNTM) stock?
The outstanding short interest for QUANTUM BIOPHARMA LTD (QNTM) is 1.42% of its float. Check the ownership tab for more information on the QNTM short interest.
QNTM Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to QNTM. When comparing the yearly performance of all stocks, QNTM is one of the better performing stocks in the market, outperforming 97.87% of all stocks.
QNTM Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
QNTM Forecast & Estimates
7 analysts have analysed QNTM and the average price target is 33.42 USD. This implies a price increase of 95.12% is expected in the next year compared to the current price of 17.13.